Below, we present a review of the literature regarding the role of ATX and ENNP2 expression in the malignancy that it is more studied, i.e., breast cancer (BC), focusing on its potential implementation as a liquid biopsy biomarker. Here, ENPP2 is linked to breast carcinoma.